Clinical trialNCT04109742WithdrawnPhase 2Interventional

Curcumin for Pediatric Nonalcoholic Fatty Liver Disease

SponsorColumbia UniversityEnrollment0NAFLD - Nonalcoholic Fatty Liver DiseaseNASH - Nonalcoholic Steatohepatitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a single-center, randomized, double-blinded, placebo-controlled, parallel treatment groups phase 2a study of curcumin for pediatric nonalcoholic fatty liver disease (NAFLD).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Joel E Lavine, MD, PhD
Columbia University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo curcumin capsulePhosphatidylcholine-curcumin complex supplement

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 9 Dec 2019
Primary completion: 22 Apr 2020
Completion: 22 Apr 2020
Last update posted: 27 Sept 2021
Registered enrollment: 0
Registry id: NCT04109742

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.